# Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)

> **NCT00979940** · NA · TERMINATED · sponsor: **Indiana University** · enrollment: 60 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00979940
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2014-06
- **Final completion:** 2014-08
- **Target enrollment:** 60 (ACTUAL)
- **Why stopped:** Slower than anticipated enrollment for pilot study.
- **Last updated:** 2015-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979940, "Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00979940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*